On 2025-05-06, Nuvectis Pharma, Inc. (NVCT) announced earnings per share of $-0.27 for the fiscal quarter ending 2025-03-31, beating the average analyst estimate of $-0.30.
The next expected annoucement date for quarterly earnings is 2025-08-05, with an average estimated earnings per share of $-0.25 for the fiscal quarter ending 2025-06-30.
Note: Earnings figures are calculated as diluted earnings per share before non-recurring items and including employee stock options expenses.
| Announcement Date | Fiscal Quarter End | Estimated EPS | Actual EPS |
|---|---|---|---|
| 2025-05-06 | 2025-03-31 | $-0.30 | $-0.27 |
| 2025-02-25 | 2024-12-31 | $-0.28 | $-0.36 |
| 2024-11-05 | 2024-09-30 | $-0.26 | $-0.24 |
| 2024-08-06 | 2024-06-30 | $-0.26 | $-0.26 |
| 2024-05-07 | 2024-03-31 | $-0.40 | $-0.25 |
| 2024-03-05 | 2023-12-31 | $-0.40 | $-0.41 |
| 2023-11-08 | 2023-09-30 | $-0.38 | $-0.37 |
| 2023-08-09 | 2023-06-30 | $-0.34 | $-0.38 |
| 2023-05-10 | 2023-03-31 | $-0.44 | $-0.27 |
| 2023-03-07 | 2022-12-31 | $-0.36 | $-0.48 |
| 2022-11-08 | 2022-09-30 | $-0.27 | $-0.42 |
| 2022-08-05 | 2022-06-30 | $-0.24 | $-0.28 |
| 2022-05-10 | 2022-03-31 | $-0.23 | $-0.32 |